Login
Toggle navigation
Videos
Categories
Trending
Franck Mouthon, co-founder and CEO of Theranexus
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Franck Mouthon, co-founder and CEO of Theranexus
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
David Kudla on the Future of Stocks: Opportunities for Investors | Jim Kotagides, President , TTG Financial Inc.
00:10:00
Camino a la excelencia translates to "Pathway to excellence."
00:10:00
Bit Digital CEO on Q2 Earnings, Headwinds in the Mining Industry | Bryan Bullett, CEO, Bit Digital IncBTBT:NAQ
00:10:00
Clocktower Technology Ventures partners with phenomenal entrepreneurs|Adriana Saman,Director,Clocktower Technology Ventures
00:10:00
Greenland Minerals: Pioneering Rare Earths and Uranium for a Sustainable Future
00:10:00
Partners with exceptional entrepreneurs starting at the earliest stages of the climb|Erica Brescia,Managing Director,Redpoint
00:10:00
125 Years of Commitment: Nuveen's Enduring Legacy in Municipal Bonds | Jose Minaya , CEO , Nuveen Investments.
00:10:00
VOXR: Quality Portfolio & Disciplined Strategy Fuel Cash Flow Growth | Kyle Floyd, CEO & Chairman of Vox Royalty Corp.
00:10:00
A brief description of Alpha Seven Energy | Tom Reed, CEO, Alpha Energy Holdings Ltd 5TS:SES
00:10:00
Eric H on Retail Investment Trends and Opportunities | Erik Hirsch, CEO, Hamilton Lane.
00:10:00
Proact President & CEO Jonas Hasselberg discusses the company's strategic vision, growth, and innovation in a fireside chat.
00:10:00
Letting Go: The Emotional Journey of Selling Your Business|Michael Bloch,Partner,Quiet Capital